GlassScriptPhysician profile
Brittany Mathis Haloua
NPI 1790204303
$5,146.62
in general payments reported to CMS, 2019-2025
51 companies · $2,453 in 2025
The $2,453 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,074 · 2023: $31.46 · 2024: $1,588 · 2025: $2,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,675 · Education: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,675.32 |
| Education | $396.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $456.87 | 2021 | |
| Merck Sharp & Dohme LLC | $452.87 | 2024-2025 | Keytruda, Lynparza, Welireg |
| Incyte Corporation | $426.22 | 2024-2025 | Monjuvi, Jakafi, Zynyz |
| Janssen Biotech, INC. | $425.78 | 2024-2025 | Rybrevant, Carvykti, Erleada |
| Novartis Pharmaceuticals Corporation | $409.67 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $228.37 | 2024-2025 | Libtayo |
| Eisai INC. | $226.69 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $175.94 | 2021-2025 | Calquence, Imfinzi, Enhertu |
| Amarin Pharma, INC. | $147.82 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $129.39 | 2021-2025 | |
| Sobi, INC | $127.24 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $111.42 | 2021-2025 | Opdivo, Krazati |
| Lilly USA, LLC | $106.30 | 2024-2025 | Jaypirca, Verzenio, Retevmo |
| Seagen INC. | $99.95 | 2025 | |
| Glaxosmithkline, LLC. | $88.92 | 2024-2025 | Ojjaara, Blenrep |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Haloua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.